Agrylin Capsule
Product Images NDC 54092-063

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Agrylin (NDC 54092-063). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Imprint (Agrylin 01)

FDA Label Image

Chemical Structure (Agrylin 02)

FDA Label Image

Figure 1 (Agrylin 03)

Patients with Thrombocytosis Secondary to Myeloproliferative Disorders were studied for their Platelet Count during Anagrelide Therapy. The data represents the Mean Platelet Count of 923 to 55 patients over 208 weeks of treatment.*

FDA Label Image

Principal Display Panel (0.5 mg Capsule Bottle Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.